|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 190,300.00 KRW | +2.42% |
|
+7.27% | +10.40% |
| 08-04 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 07-24 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.42% | +7.27% | +3.65% | +1.02% | +10.40% | +14.90% | +44.79% | -14.11% | +160.39% | 29.86B | |
| +0.90% | -2.33% | -3.27% | +14.52% | +4.39% | +0.68% | +14.52% | -21.85% | +205.94% | 48B | |
| +1.61% | +8.78% | +3.59% | +33.69% | +147.09% | +412.65% | +563.98% | +596.90% | - | 41.13B | |
| +3.83% | -4.75% | +14.49% | +33.66% | +4.61% | +28.20% | +7.53% | -5.07% | +203.17% | 37.56B | |
| +2.04% | +1.07% | +6.87% | +11.17% | +8.86% | +7.65% | +76.37% | -1.54% | +1,148.47% | 35.91B | |
| +0.31% | -2.52% | -8.30% | +9.06% | - | - | - | - | - | 16.12B | |
| +1.23% | -0.71% | +2.77% | +34.96% | +3.40% | +33.11% | +123.04% | +222.38% | - | 16.05B | |
| +1.25% | +1.52% | +1.43% | +18.62% | +11.67% | +4.62% | +18.66% | -38.05% | +80.21% | 13.76B | |
| +4.39% | -8.24% | -4.36% | +34.76% | -10.28% | -1.50% | -35.01% | -32.87% | +113.88% | 12.1B | |
| +10.40% | +9.77% | +11.37% | +39.03% | +29.21% | +53.89% | +25.56% | -37.13% | +200.68% | 11.28B | |
| +0.01% | +0.07% | +1.64% | +27.17% | +22.56% | +31.92% | -11.33% | -41.24% | +156.01% | 11.23B | |
| +0.37% | +0.65% | -15.36% | +3.41% | -9.39% | +81.83% | +562.01% | +294.58% | +2,385.19% | 10.79B | |
| -0.04% | -0.03% | +0.49% | +61.07% | +77.74% | +250.00% | +554.41% | - | - | 10.07B | |
| +0.10% | +5.94% | +35.14% | +36.34% | +40.56% | +34.05% | +36.06% | -60.42% | - | 9.85B | |
| -1.43% | +0.80% | -34.52% | -27.61% | -31.15% | +26.53% | +39.24% | +38.32% | +50.80% | 9.15B | |
| -1.61% | -0.36% | +6.41% | +22.53% | -11.99% | -20.77% | -17.46% | -29.26% | +33.36% | 8.75B | |
| +0.14% | +2.82% | +3.99% | +37.84% | +56.57% | +153.71% | +622.40% | +183.77% | - | 8.73B | |
| +1.52% | +8.32% | +0.56% | -5.41% | +6.96% | +559.67% | +2,177.03% | +42.68% | - | 8.64B | |
| +0.46% | -0.09% | -8.37% | +27.14% | +35.15% | +144.73% | +423.71% | +68.88% | - | 8.59B | |
| +0.52% | +14.08% | -21.91% | -12.34% | -19.73% | -17.91% | - | - | - | 8.49B | |
| Average | +1.41% | +0.04% | -0.18% | +20.03% | +19.82% | +94.63% | +290.31% | +68.59% | +430.74% | 17.8B | |
| Weighted average by Cap. | +1.65% | -0.41% | +1.75% | +20.43% | +26.81% | +92.35% | +212.17% | +92.86% | +422.68% |
- Stock Market
- Stocks
- A068270 Stock
- Sector Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
